260 related items for PubMed ID: 26759000
1. Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.
Raman V, Krishnamurthy S, Harichandrakumar KT.
Pediatr Nephrol; 2016 Apr; 31(4):595-604. PubMed ID: 26759000
[Abstract] [Full Text] [Related]
2. Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome.
Basu B, Bhattacharyya S, Barua S, Naskar A, Roy B.
Clin Exp Nephrol; 2020 Jul; 24(7):622-629. PubMed ID: 32201918
[Abstract] [Full Text] [Related]
3. Three-monthly bolus vitamin D supplements (1000 vs 400 IU/day) for prevention of bone loss in children with difficult-to-treat nephrotic syndrome: a randomised clinical trial.
Singh DN, Krishnamurthy S, Kamalanathan SK, Harichandrakumar KT, Sivamurukan P.
Paediatr Int Child Health; 2018 Nov; 38(4):251-260. PubMed ID: 30092157
[Abstract] [Full Text] [Related]
4. Effect of two prophylactic bolus vitamin D dosing regimens (1000 IU/day vs. 400 IU/day) on bone mineral content in new-onset and infrequently-relapsing nephrotic syndrome: a randomised clinical trial.
Muske S, Krishnamurthy S, Kamalanathan SK, Rajappa M, Harichandrakumar KT, Sivamurukan P.
Paediatr Int Child Health; 2018 Feb; 38(1):23-33. PubMed ID: 28466679
[Abstract] [Full Text] [Related]
5. Long term tapering versus standard prednisolone treatment for first episode of childhood nephrotic syndrome: phase III randomised controlled trial and economic evaluation.
Webb NJA, Woolley RL, Lambe T, Frew E, Brettell EA, Barsoum EN, Trompeter RS, Cummins C, Deeks JJ, Wheatley K, Ives NJ, PREDNOS Collaborative Group.
BMJ; 2019 May 23; 365():l1800. PubMed ID: 31335316
[Abstract] [Full Text] [Related]
6. Prolonged versus standard prednisolone therapy for initial episode of idiopathic nephrotic syndrome.
Mishra OP, Thakur N, Mishra RN, Prasad R.
J Nephrol; 2012 May 23; 25(3):394-400. PubMed ID: 21928226
[Abstract] [Full Text] [Related]
7. Efficacy of low-dose daily versus alternate-day prednisolone in frequently relapsing nephrotic syndrome: an open-label randomized controlled trial.
Yadav M, Sinha A, Khandelwal P, Hari P, Bagga A.
Pediatr Nephrol; 2019 May 23; 34(5):829-835. PubMed ID: 30194663
[Abstract] [Full Text] [Related]
8. Short-Duration Prednisolone in Children with Nephrotic Syndrome Relapse: A Noninferiority Randomized Controlled Trial.
Kainth D, Hari P, Sinha A, Pandey S, Bagga A.
Clin J Am Soc Nephrol; 2021 Feb 08; 16(2):225-232. PubMed ID: 33478976
[Abstract] [Full Text] [Related]
9. Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment.
Fujinaga S, Hirano D, Mizutani A, Sakuraya K, Yamada A, Sakurai S, Shimizu T.
Clin Exp Nephrol; 2017 Aug 08; 21(4):671-676. PubMed ID: 27558467
[Abstract] [Full Text] [Related]
10. A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.
Hiraoka M, Tsukahara H, Matsubara K, Tsurusawa M, Takeda N, Haruki S, Hayashi S, Ohta K, Momoi T, Ohshima Y, Suganuma N, Mayumi M, West Japan Cooperative Study Group of Kidney Disease in Children.
Am J Kidney Dis; 2003 Jun 08; 41(6):1155-62. PubMed ID: 12776266
[Abstract] [Full Text] [Related]
11. Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
El-Husseini A, El-Basuony F, Mahmoud I, Sheashaa H, Sabry A, Hassan R, Taha N, Hassan N, Sayed-Ahmad N, Sobh M.
Nephrol Dial Transplant; 2005 Nov 08; 20(11):2433-8. PubMed ID: 16204303
[Abstract] [Full Text] [Related]
12. Can we predict relapses in children with idiopathic steroid-sensitive nephrotic syndrome?
Mishra OP, Abhinay A, Mishra RN, Prasad R, Pohl M.
J Trop Pediatr; 2013 Oct 08; 59(5):343-9. PubMed ID: 23619602
[Abstract] [Full Text] [Related]
13. Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.
Sinha A, Saha A, Kumar M, Sharma S, Afzal K, Mehta A, Kalaivani M, Hari P, Bagga A.
Kidney Int; 2015 Jan 08; 87(1):217-24. PubMed ID: 25029428
[Abstract] [Full Text] [Related]
14. Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome.
Gulati A, Sinha A, Gupta A, Kanitkar M, Sreenivas V, Sharma J, Mantan M, Agarwal I, Dinda AK, Hari P, Bagga A.
Kidney Int; 2012 Nov 08; 82(10):1130-5. PubMed ID: 22763815
[Abstract] [Full Text] [Related]
15. Induction prednisone dosing for childhood nephrotic syndrome: how low should we go?
Sibley M, Roshan A, Alshami A, Catapang M, Jöbsis JJ, Kwok T, Polderman N, Sibley J, Matsell DG, Mammen C, Pediatric Nephrology Clinical Pathway Development Team.
Pediatr Nephrol; 2018 Sep 08; 33(9):1539-1545. PubMed ID: 29789934
[Abstract] [Full Text] [Related]
16. Study protocol: high-dose mizoribine with prednisolone therapy in short-term relapsing steroid-sensitive nephrotic syndrome to prevent frequent relapse (JSKDC05 trial).
Hama T, Nakanishi K, Ishikura K, Ito S, Nakamura H, Sako M, Saito-Oba M, Nozu K, Shima Y, Iijima K, Yoshikawa N, Japanese Study Group of Kidney Disease in Children (JSKDC).
BMC Nephrol; 2018 Sep 10; 19(1):223. PubMed ID: 30200895
[Abstract] [Full Text] [Related]
17. Should we stop dosing steroids per body surface area for nephrotics?
Filler G, Robinson LA.
Pediatr Nephrol; 2016 Apr 10; 31(4):519-22. PubMed ID: 26712382
[Abstract] [Full Text] [Related]
18. Prednisone dosing per body weight or body surface area in children with nephrotic syndrome: is it equivalent?
Feber J, Al-Matrafi J, Farhadi E, Vaillancourt R, Wolfish N.
Pediatr Nephrol; 2009 May 10; 24(5):1027-31. PubMed ID: 19165504
[Abstract] [Full Text] [Related]
19. [Glucocorticoid therapy for children with idiopathic nephrotic syndrome].
Kadowaki J.
Hokkaido Igaku Zasshi; 1994 May 10; 69(3):403-10. PubMed ID: 7927169
[Abstract] [Full Text] [Related]
20. Older boys benefit from higher initial prednisolone therapy for nephrotic syndrome. The West Japan Cooperative Study of Kidney Disease in Children.
Hiraoka M, Tsukahara H, Haruki S, Hayashi S, Takeda N, Miyagawa K, Okuhara K, Suehiro F, Ohshima Y, Mayumi M.
Kidney Int; 2000 Sep 10; 58(3):1247-52. PubMed ID: 10972687
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
